{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:22:13Z","timestamp":1787775733153,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>The purpose of this study was to evaluate the outcomes of phacoemulsification with intravitreal triamcinolone acetonide (IVTA) injection in patients with cataract and diabetic macular edema (DME) across the grades of diabetic retinopathy (DR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>It was a retrospective observational study. The study included 70 patients (75 eyes) with cataract and clinically significant macular edema in diabetics with nonproliferative (61 eyes) or proliferative (14 eyes) DR who underwent phacoemulsification with IVTA. Visual outcome and progression of DME over 3 months were studied in terms of the best-corrected visual acuity (BCVA) and central macular thickness (CMT), respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The case records of 70 patients (75 eyes) were studied. The mean baseline BCVA (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 75) in the logMAR scale \u00b1 SD was 0.92 \u00b1 0.53. 3 weeks after the surgery, the mean BCVA improved to 0.39 \u00b1 0.26 and the mean CMT (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 40) was 382.57 \u00b1 192.30 compared with the mean preoperative CMT of 480.57 \u00b1 163.25 in the same set (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01). The mean CMT decreased at 3 weeks in 22 (55% of the eyes). An improvement of \u22652 lines was seen at 3 weeks in 52 (69.33%) eyes and in 49 (65.33%) eyes at 3 months. The mean CMT at 3 months was 445.51 \u00b1 222.99 (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 70) compared to the preoperative mean CMT of 470.72 \u00b1 176.15 in the same set (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.29). The mean CMT decreased at 3 months in 34 (48.5%) eyes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Phacoemulsification with IVTA injection improved the mean visual acuity at 3 weeks and 3 months in two-thirds of cases and decreased the mean CMT at 3 weeks in nearly half the numbers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ojo.ojo_75_23","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T02:01:07Z","timestamp":1708480867000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Phacoemulsification in patients with diabetic macular edema \u2013 A real-world data of 75 eyes"],"prefix":"10.4103","volume":"17","author":[{"given":"Shikha Talwar","family":"Bassi","sequence":"first","affiliation":[{"name":"Department of Neuroophthalmology Services, Sankara Nethralaya, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shebin","family":"Salim","sequence":"additional","affiliation":[{"name":"Department of Comprehensive Ophthalmology Services, Sankara Nethralaya, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Rishi","sequence":"additional","affiliation":[{"name":"Department of Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"R1-20240918","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0002-9394(14)71857-4","article-title":"Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation","volume":"114","author":"Jaffe","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"R2-20240918","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bjo.86.5.565","article-title":"A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes","volume":"86","author":"Squirrell","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R3-20240918","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(99)00033-1","article-title":"Patterns of diabetic macular edema with optical coherence tomography","volume":"127","author":"Otani","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R4-20240918","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R5-20240918","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"R6-20240918","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2174\/1566524014666140128114414","article-title":"Glucocorticoids:Structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema","volume":"14","author":"Zhang","year":"2014","journal-title":"Curr Mol Med"},{"key":"R7-20240918","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/IAE.0000000000000726","article-title":"Intravitreal corticosteroids in diabetic macular edema:Pharmacokinetic considerations","volume":"35","author":"Yang","year":"2015","journal-title":"Retina"},{"key":"R8-20240918","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archopht.122.3.336","article-title":"Safety of an intravitreal injection of triamcinolone:Results from a randomized clinical trial","volume":"122","author":"Gillies","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R9-20240918","doi-asserted-by":"crossref","first-page":"6253","DOI":"10.1167\/iovs.10-5414","article-title":"Prevalence and risk factors for cataract in diabetes:Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study, report no. 17","volume":"51","author":"Raman","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-20240918","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0161-6420(98)91020-X","article-title":"The Wisconsin epidemiologic study of diabetic retinopathy:XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes","volume":"105","author":"Klein","year":"1998","journal-title":"Ophthalmology"},{"key":"R11-20240918","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0161-6420(99)90148-3","article-title":"The natural history of macular edema after cataract surgery in diabetes","volume":"106","author":"Dowler","year":"1999","journal-title":"Ophthalmology"},{"key":"R12-20240918","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ophtha.2006.08.053","article-title":"Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography","volume":"114","author":"Kim","year":"2007","journal-title":"Ophthalmology"},{"key":"R13-20240918","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000362764","article-title":"Update of intravitreal steroids for the treatment of diabetic macular edema","volume":"52","author":"Bandello","year":"2014","journal-title":"Ophthalmic Res"},{"key":"R14-20240918","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"R15-20240918","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/IAE.0b013e318165767e","article-title":"Intravitreal triamcinolone for diabetic macular edema:Comparison of 1, 2, and 4 mg","volume":"28","author":"Hauser","year":"2008","journal-title":"Retina"},{"key":"R16-20240918","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1600-0420.2006.00700.x","article-title":"Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema:6-month results of a prospective controlled trial","volume":"84","author":"Audren","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"R17-20240918","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.ophtha.2009.04.049","article-title":"Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema","volume":"116","author":"Gillies","year":"2009","journal-title":"Ophthalmology"},{"key":"R18-20240918","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema:Preliminary results of a prospective controlled trial","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"R19-20240918","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ophtha.2008.06.015","article-title":"A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"R20-20240918","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.ophtha.2007.02.006","article-title":"Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema:Six-month outcomes","volume":"114","author":"Lam","year":"2007","journal-title":"Ophthalmology"},{"key":"R21-20240918","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3129\/i09-086","article-title":"Visual acuity after intravitreal triamcinolone for diabetic macular edema refractory to laser treatment:A meta-analysis","volume":"44","author":"Rudnisky","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"R22-20240918","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2415-5-15","article-title":"The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract","volume":"5","author":"Habib","year":"2005","journal-title":"BMC Ophthalmol"},{"key":"R23-20240918","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.eye.6701686","article-title":"Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema:A 6-month prospective pilot study","volume":"19","author":"Lam","year":"2005","journal-title":"Eye (Lond)"},{"key":"R24-20240918","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.sjopt.2015.10.004","article-title":"The combination of phacoemulsification surgery and intravitreal triamcinolone injection in patients with cataract and diabetic macular edema","volume":"30","author":"Ozgur","year":"2016","journal-title":"Saudi J Ophthalmol"},{"key":"R25-20240918","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jcrs.2009.12.030","article-title":"Effect of intravitreal triamcinolone acetonide injection on central macular thickness in diabetic patients having phacoemulsification","volume":"36","author":"Ahmadabadi","year":"2010","journal-title":"J Cataract Refract Surg"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_75_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:40:50Z","timestamp":1787773250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_75_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_75_23","relation":{},"ISSN":["0974-620X","0974-7842"],"issn-type":[{"value":"0974-620X","type":"print"},{"value":"0974-7842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-04-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}